ABSCI CORPORATION - CO

Absci to Participate in Upcoming Investor Conferences

20 May 2025 05:00:00 By Nasdaq GlobeNewswire

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

13 May 2025 13:05:00 By Nasdaq GlobeNewswire

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

13 May 2025 13:01:00 By Nasdaq GlobeNewswire

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

14 Apr 2025 13:05:00 By Nasdaq GlobeNewswire

Absci to Participate in Upcoming Investor Conferences

26 Mar 2025 05:00:01 By Nasdaq GlobeNewswire

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

18 Mar 2025 13:05:00 By Nasdaq GlobeNewswire

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

04 Mar 2025 13:05:00 By Nasdaq GlobeNewswire

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

04 Mar 2025 13:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

04 Mar 2025 05:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

18 Feb 2025 05:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

22 Jan 2025 05:00:00 By Nasdaq GlobeNewswire

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

10 Jan 2025 04:30:00 By Nasdaq GlobeNewswire

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

08 Jan 2025 04:00:00 By Nasdaq GlobeNewswire

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

06 Jan 2025 05:00:01 By Nasdaq GlobeNewswire

Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

02 Jan 2025 05:00:00 By Nasdaq GlobeNewswire

Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day

12 Dec 2024 05:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference

21 Nov 2024 05:00:00 By Nasdaq GlobeNewswire

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

12 Nov 2024 04:30:00 By Nasdaq GlobeNewswire

Absci to Host R&D Day on December 12, 2024

07 Nov 2024 05:00:01 By Nasdaq GlobeNewswire

Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI

31 Oct 2024 05:00:00 By Nasdaq GlobeNewswire